← Back to headlines
I-Mab Biopharma Reports GAAP EPS of -$0.48
I-Mab Biopharma has released its latest financial report, indicating a GAAP EPS of -$0.48. The results provide an update on the biopharmaceutical company's earnings per share.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
